Prenatal Testing And Newborn Screening Market 2020–2030: Global Industry Analysis, Size, Share, Growth, Trends and Forecast | COVID 19 Growth And Change

The Business Research Company offers "Prenatal Testing And Newborn Screening Global Market Report 2020-30: COVID 19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

The global prenatal testing and newborn screening market is expected to decline from $4.39 billion in 2019 to $4.18 billion in 2020 at a compound annual growth rate (CAGR) of -4.79%. The decline is mainly due to the COVID-19 outbreak that has led to deferred care in order to avoid visiting hospitals, which resulted in reduced patient volume. The market is then expected to recover and reach $6.04 billion in 2023 at a CAGR of 13.09%.

Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3350

The prenatal testing and newborn screening tests market consists of sales of prenatal testing and newborn screening tests services and related goods by entities (organizations, sole traders and partnerships) that provide prenatal testing and newborn screening tests, which help to determine various genetic and chromosomal diseases, to provide timely medical or surgical treatment of a condition before or after birth. Genetic diseases such as sickle cell, down’s syndrome, cystic fibrosis and muscular dystrophy are detected with the help of these tests. Only goods and services traded between entities or sold to end consumers are included.

Growth of the prenatal testing and newborn screening market may be hampered by the relatively low healthcare access in most developing countries, compared to the developed nations. For instance, in India, there were only about 1.9 million hospital beds for 1.33 billion people, as of 2020. Low access to healthcare services and the lack of sufficient hospitals and healthcare professionals harmed market growth in many developing nations. Moreover, low disposable income in many countries further lowers the access to healthcare services, thus negatively hampering the growth of the prenatal testing and newborn screening market.

Prenatal Testing And Newborn Screening Market Segmentation: -
By Technology
Ion Semiconductor Sequencing
Pyro-Sequencing
Synthesis Sequencing
Real Time Sequencing
Ligation Sequencing
Reversible Dye Termination Sequencing
Nano-Pore Sequencing

By Application
Screening
Companion Diagnostics
Other Diagnostics

By End User
Hospital Laboratories
Clinical Research Oraganizations
Diagnostic laboratories

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report-2020-30-covid-19-growth-and-change

Few Points From Table Of Content
1. Executive Summary
2. Prenatal Testing And Newborn Screening Market Characteristics
3. Prenatal Testing And Newborn Screening Market Size And Growth
4. Prenatal Testing And Newborn Screening Market Segmentation
5. Prenatal Testing And Newborn Screening Market Regional And Country Analysis
.
.
25. Prenatal Testing And Newborn Screening Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Prenatal Testing And Newborn Screening Market
27. Prenatal Testing And Newborn Screening Market Trends And Strategies
28. Prenatal Testing And Newborn Screening Market Future Outlook and Potential Analysis
29. Appendix

The report covers the trends and market dynamics of the Prenatal Testing And Newborn Screening Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

Some of the key players involved in the Clinical Oncology Next Generation Sequencing Market are PerkinElmer, Progenity, Laboratory Corporation of America Holdings (Sequenom), Natera, Invitae, Centogene, Cradle Genomics.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.